Indivior Pharmaceuticals (INDV) Accumulated Depreciation & Amortization (2022 - 2025)
Historic Accumulated Depreciation & Amortization for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to $8.0 million.
- Indivior Pharmaceuticals' Accumulated Depreciation & Amortization fell 2727.27% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 2727.27%. This contributed to the annual value of $29.0 million for FY2024, which is 9333.33% up from last year.
- As of Q3 2025, Indivior Pharmaceuticals' Accumulated Depreciation & Amortization stood at $8.0 million, which was down 2727.27% from $5.0 million recorded in Q2 2025.
- Indivior Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $29.0 million for Q4 2024, and its period low was $5.0 million during Q1 2024.
- Its 5-year average for Accumulated Depreciation & Amortization is $10.7 million, with a median of $7.5 million in 2024.
- In the last 5 years, Indivior Pharmaceuticals' Accumulated Depreciation & Amortization soared by 16666.67% in 2022 and then crashed by 2857.14% in 2025.
- Quarter analysis of 5 years shows Indivior Pharmaceuticals' Accumulated Depreciation & Amortization stood at $6.0 million in 2021, then surged by 166.67% to $16.0 million in 2022, then decreased by 6.25% to $15.0 million in 2023, then soared by 93.33% to $29.0 million in 2024, then crashed by 72.41% to $8.0 million in 2025.
- Its Accumulated Depreciation & Amortization was $8.0 million in Q3 2025, compared to $5.0 million in Q2 2025 and $5.0 million in Q1 2025.